University of Cambridge > Talks.cam > MRC Mitochondrial Biology Unit Seminars > Targeting liver mitochondria to treat MASLD/MASH and cardiometabolic disease

  Browse A-Z

Log in

Googledetails Microsoftdetails

🔐 Log In

Information on

Subscribing to talksdetails Finding a talkdetails Adding a talkdetails Disseminating talksdetails Help and Documentationdetails

ℹ️ Information

Targeting liver mitochondria to treat MASLD/MASH and cardiometabolic disease

Download to your calendar using vCal

If you have a question about this talk, please contact Lisa Arnold .

Insulin resistance is a critical factor in the pathogenesis of type 2 diabetes. In addition insulin resistance plays a key role in the pathogenesis of MASLD /MASH, heart disease, obesity-associated cancers and Alzheimer’s disease. In this lecture I will review recent studies that have demonstrated the safety and efficacy of liver-targeted mitochondrial uncoupling agents to treat these diseases in both animal models and humans with MASLD /MASH and cardiometabolic disease. I will also review some novel 13C NMR and LC-MS/MS methods (PINTA and Q-Flux) that we have recently developed to assess rates of hepatic mitochondrial oxidation and anaplerotic fluxes in vivo.

This talk is part of the MRC Mitochondrial Biology Unit Seminars series.

This talk is included in these lists:

Note that ex-directory lists are not shown.

Other lists

Martin Ryle Seminar Room, Kavli Institute Senior Parlour, Gonville & Caius College virtual ZOOM meeting ID: 263 591 6003, https://zoom.us/j/2635916003

Other talks

Talk TBC Title and abstract tba Cooperation for Nature Title TBC Title TBC Discussion I
 

© 2006-2025 Talks.cam, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity